Share

May 26, 2020; 94 (21) Special Editorial

COVID-19 is catalyzing the adoption of teleneurology

Brad C. Klein, Neil A. Busis
First published April 1, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009494
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2774

Share

Article Information

vol. 94 no. 21 903-904
DOI: 
https://doi.org/10.1212/WNL.0000000000009494
PubMed: 
32238505
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 1, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Brad C. Klein, MD, MBA and
    2. Neil A. Busis, MD
  1. Brad C. Klein, MD, MBA and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Allergan, (2) Amgen, (3) Biohaven, (4) Eagalet, (5) Eli Lilly, (6) Lundbeck, (7) Promius, (8) Teva, (9) US WorldMeds.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Abington Neurological Associates, Ltd., Chief Operating Officer, 12 years

    Consultancies:

    1. (1) Allergan, (2) Amgen, (3) Biohaven, and (4) Promius

    Speakers' Bureaus:

    1. (1) Allergan, (2) Amgen, (3) Biohaven, (4) Eagalet, (5) Eli Lilly, (6) Lundbeck, (7) Promius, (8) Teva, (9) US WorldMeds.

    Other activities:

    1. Equity interest in AppsByDocs, LLC, makers of p-cog.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Alder, (2) Allergan, and (3) Eli Lilly

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Neil A. Busis, MD
    3. Scientific Advisory Boards:

    1. Alternate CPT Advisor for American Academy of Neurology on the CPT Advisory Committee. CPT is operated by the American Medical Association

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker at courses sponsored by the American Academy of Neurology

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Former Member of the American Academy of Neurology Board of Directors. Only travel expenses until April, 2017 were reimbursed.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Abington Hospital (B.C.K.), Department of Neurology, Thomas Jefferson University, Philadelphia, PA; and Department of Neurology (N.A.B.), NYU Langone Health, New York.
  1. Correspondence
    Dr. Klein bradcklein{at}gmail.com
View Full Text

Article usage

Article usage: April 2020 to March 2021

AbstractFullPdfSource
Apr 2020336901259Highwire
May 2020788600527Highwire
Jun 2020217327257Highwire
Jul 2020147241152Highwire
Aug 20207115681Highwire
Sep 2020110187128Highwire
Oct 202012221090Highwire
Nov 20206018093Highwire
Dec 2020198642Highwire
Jan 20212722755Highwire
Feb 20212722445Highwire
Mar 20211524345Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me